EP300 and lymphoma: CBP/p300 mutant proteins found in some diffuse large B-cell lymphomas (DLBCLs) show a reduced ability to acetylate BCL6 [88], and therefore such lymphoma cells have increased BCL6 activity, which is related to the oncogenic state of these cells.